fashion -WSS

fashion

author：explore 2025-09-06 04:36:16 - browse：4

Christine Kao/STAT

The biggest enticement that large pharmacy benefit managers offer to the employers that hire them is drug rebates — a steady stream of money sent back to their clients, a tangible symbol of the discounts that PBMs are able to wrangle out of pharmaceutical companies.

PBMs, the middlemen of drug pricing negotiations, also claim portions of those lucrative rebates for themselves. So when new market developments threaten to diminish or wipe away that revenue stream, PBMs find crafty ways to keep as much of those dollars as possible — often at the expense of employers.

One such case occurred last year, when a wave of Humira biosimilars entered the market and drug companies slashed the list prices of their insulin products. CVS Caremark, the PBM owned by CVS Health that oversees the prescription drug benefits of 103 million people, told its employer clients that it anticipated “more lower-cost products (including specialty biosimilars) may become preferred products” on its lists of approved drugs for 2024, according to documents obtained by STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Would Medicare drug price negotiations stall in a shutdown?

WSS

For BCIs, commercial hurdles may be bigger than scientific ones

Data show record exodus of life scientists from academia

For BCIs, commercial hurdles may be bigger than scientific ones

FDA seeks to regulate lab

FDA seeks to regulate lab

ER docs worry over extreme heat as a 'mass casualty event'

explore

fashion

Wikipedia

At least 13 dead in Texas as scorching temps continue

'Ancient DNA,' 23andMe reveal African American ancestries

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How one patient went off dialysis — and others can too

Psychedelics group wrestles with new pharma identity

For BCIs, commercial hurdles may be bigger than scientific ones

Alkermes shareholders re

Medicaid, Medicare dual

Drug repurposing or repositioning? The language matters

How one patient went off dialysis — and others can too

leisure time

After a drawn out lobbying fight, ARPA

A cyberattack has disrupted hospitals and health care in several states

Influencer to be charged after chaos erupts in New York City's Union Square

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Biogen shutters digital health group, ends Apple study, in cost cutting move

Microsoft strikes partnership with Duke Health to advance health AI

focus

leisure time

leisure time

knowledge